Recombinant Human CD40 Ligand (CD40LG) | Z100125

abm | Recombinant Human CD40 Ligand (CD40LG) | Z100125

CD40LG protein is expressed on all B lymphocytes during various stages of development, activated T cells and monocytes, follicular dendritic cells, thymic epithelial cells, and various carcinoma cell lines. It is expressed on most mature B cell malignancies and on some early B cell acute lymphocytic leukemias. Human CD40LG has been found to be the receptor for a protein involved in an X-linked immunodeficiency syndrome. Based on its homology with other members of the TNF ligand protein superfamily, CD40LG is also referred to also as TNFSF5. The soluble form of CD40LG is generated by the intracellular proteolytic processing of the full length CD40LG. Recombinant Human CD40LG is a 17 kDa protein that represents the soluble segment of full length CD40LG and encompasses the receptor binding TNF-like domain.

Functions:

The ED50 as determined by dose-dependent proliferation of acute myeloid leukemia was found to be <5 ng/ml

Organism:

Human

Source:

E. coli

Alias:

Soluble CD40 Ligand, Tumor necrosis factor ligand superfamily member 5, TNFSF5, TNF-related activation protein, TRAP, CD154, gp39, T-BAM, CD40, T cell antigen Gp39, CD-40L

Gene Symbol:

CD40LG

Gene ID:

959

Accession:

P29965

Formulation:

Lyophilized from a 0.2 μm filtered solution in PBS (pH 7.0)

Solubility:

A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.

Appearance:

Lyophilized Powder

Molecular Weight (kDa):

16

Molecular Weight 2 (kDA):

N/A

Molecular Weight 3 (kDA):

N/A

Purity:

>95% as determined by SDS-PAGE

Concentration:

<1.0 EU/μg of recombinant protein as determined by the LAL method

Shipping Condition :

Ambient Temperature

Storage Condition:

The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.